Professor of Pathology and Associate Dean Medical College of Georgia Augusta University MARTINEZ, Georgia, United States
Next-generation sequencing (NGS) is vital for profiling solid tumor samples but faces challenges like complex workflows and bioinformatics, resulting in high costs and long turnaround times. Additionally, formalin-fixed, paraffin-embedded (FFPE) biopsies often produce poor-quality, low-quantity DNA, leading to significant failure rates with NGS, known as Quality/Quantity Not Sufficient (QNS).
Join Dr. Ravindra Kolhe, Professor and Chair of Pathology at Georgia Cancer Center, and Dr. Darren Davis, Senior Vice President at Precision For Medicine, for a workshop on a targeted workflow using the Agena MassARRAY System. This robust, cost-effective multi-gene mutation profiling approach provides rapid insights from low-input NSCLC-derived FFPE samples, achieving 100% concordance with NGS and high reproducibility, even for samples previously deemed QNS.
